Peripheral haemodynamic effects of perindopril compared in patients with congestive heart failure and in normal volunteers
- PMID: 2852235
Peripheral haemodynamic effects of perindopril compared in patients with congestive heart failure and in normal volunteers
Abstract
The effects of perindopril, 4 mg orally, on brachial artery blood flow and diameter (pulsed Doppler) and on forearm vascular resistance were investigated and compared in six normal subjects and 10 congestive heart failure patients (New York Heart Association class III or IV). Pre-drug values of brachial artery blood flow and diameter were significantly lower in patients with congestive heart failure than in normal subjects, the reverse being true for forearm vascular resistance. In normal subjects perindopril increased brachial artery blood flow and decreased forearm vascular resistance, while in patients with congestive heart failure the same effects were observed but they were more pronounced and brachial artery diameter was increased. In patients with congestive heart failure, when perindopril effects were maximal, brachial artery blood flow remained below the baseline values of normal subjects but brachial artery diameter was normalized. Finally, there was a correlation between the drug-induced decrease in forearm vascular resistance and basal plasma noradrenaline values in all subjects taken together. These results indicate that: (1) the renin-angiotensin system plays a major role in vasoconstriction in patients with congestive heart failure; (2) this vasoconstriction affects both large arteries and arterioles; (3) perindopril is able to considerably improve peripheral haemodynamics in congestive heart failure; and (4) this improvement is linked to the initial sympathetic tone.
Similar articles
-
Treatment for one year with perindopril: effect on cardiac mass and arterial compliance in essential hypertension.J Hypertens Suppl. 1988 Dec;6(3):S33-9. J Hypertens Suppl. 1988. PMID: 3225688 Clinical Trial.
-
[Peripheral hemodynamic and biological effects of perindopril in the healthy subject. Dose-effect relationship].Arch Mal Coeur Vaiss. 1986 Jun;79(6):913-8. Arch Mal Coeur Vaiss. 1986. PMID: 3026273 Clinical Trial. French.
-
Perindopril, converting enzyme blockade, and peripheral arterial hemodynamics in the healthy volunteer.J Cardiovasc Pharmacol. 1987 Jan;9(1):94-102. J Cardiovasc Pharmacol. 1987. PMID: 2434802 Clinical Trial.
-
Distinctive properties of perindopril among converting enzyme inhibitors in congestive heart failure.Can J Cardiol. 1994 Nov;10 Suppl D:13D-16D. Can J Cardiol. 1994. PMID: 7954033 Review.
-
[Cardiac hypertrophy and arterial compliance after antihypertensive treatment].Arch Mal Coeur Vaiss. 1991 Dec;84 Spec No 4:79-83. Arch Mal Coeur Vaiss. 1991. PMID: 1838923 Review. French.
Cited by
-
Newer ACE inhibitors. A look at the future.Drugs. 1990 Dec;40(6):800-28. doi: 10.2165/00003495-199040060-00004. Drugs. 1990. PMID: 2078997 Review.
-
Effects of an angiotensin converting enzyme inhibitor, ramipril, on intracranial circulation in healthy volunteers. off.Br J Clin Pharmacol. 1992 Sep;34(3):224-30. doi: 10.1111/j.1365-2125.1992.tb04128.x. Br J Clin Pharmacol. 1992. PMID: 1327051 Free PMC article. Clinical Trial.
-
Perindopril. A review of its pharmacokinetics and clinical pharmacology.Drugs. 1990;39 Suppl 1:49-63. doi: 10.2165/00003495-199000391-00009. Drugs. 1990. PMID: 2407493 Review.
-
Comparison of the pharmacokinetics and pharmacodynamics of oral doses of perindopril in normotensive Chinese and Caucasian volunteers.Br J Clin Pharmacol. 1995 Apr;39(4):361-8. doi: 10.1111/j.1365-2125.1995.tb04463.x. Br J Clin Pharmacol. 1995. PMID: 7640141 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical